CopyFind
Rosulip-ASP 150 Capsule
medicine 📍 IN

Rosulip-ASP 150 Capsule

119,79 ₹

Analogs of Rosulip-ASP 150 Capsule

Find cheaper analogs and generic equivalents for Rosulip-ASP 150 Capsule.

Ingredients

Substancja czynna: Rosuvastatin; Aspirin


Przegląd produktu

About Rosulip-ASP 150

Rosulip-ASP 150 is a medication containing the active ingredient Rosuvastatin, classified as Statin medication. Rosuvastatin, sold under the brand name Crestor among others, is a statin medication, used to prevent cardiovascular disease in those at high risk and treat dyslipidemia or hyperlipidemia. It is recommended to be used with dietary changes, exercise, and weight loss.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Rosuvastatin tablets is indicated: To reduce the risk major adverse cardiovascular (CV) events (CV death, nonfatal myocardial.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Rosuvastatin, the active ingredient in Rosulip-ASP 150, belongs to the Statin medication class. 1 INDICATIONS AND USAGE Rosuvastatin tablets is indicated: To reduce the risk major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, nonfatal stroke, or an arterial revascularization procedure) in adults without established coronary heart disease who are at increased risk of CV disease bas…. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Rosulip-ASP 150. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Rosulip-ASP 150 for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for Rosulip-ASP 150 Capsule.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.